Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study

Critical Care Medicine

Volumn 40, Issue 1, 2012, Pages 11-17

  Schwebel, Carole ^a   Lucet, Jean Christophe ^b   Vesin, Aurélien ^a,c   Arrault, Xavier ^b   Calvino Gunther, Silvia ^a   Bouadma, Lila ^b   Timsit, Jean François ^a,c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

Antiseptic dressings; Catheter related infections; Economic evaluation; Intensive care unit

Indexed keywords

CHLORHEXIDINE;

ADULT; ARTERY CATHETER; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; CRITICALLY ILL PATIENT; DISABILITY; ECONOMIC EVALUATION; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL SPONGE; WOUND DRESSING;

ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHLORHEXIDINE; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MIDDLE AGED; SURGICAL SPONGES;

EID: 84055195523     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31822f0604     Document Type: Article

References (39)

1. Suetens C, Morales I, Savey A, et al: European surveillance of ICU-acquired infections (HELICS-ICU): Methods and main results. J Hosp Infect 2007; 65:171-173
2. Mermel LA: Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132:391-402
3. National Nosocomial Infections Surveillance System: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485
4. Soufir L, Timsit JF, Mahe C, et al: Attributable morbidity and mortality of catheterrelated septicemia in critically ill patients: A matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999; 20:396-401
5. Renaud B, Brun-Buisson C, ICU-Bacteremia Study Group: Outcomes of primary and catheter-related bacteremia. A cohort and casecontrol study in critically ill patients. Am J Respir Crit Care Med 2001; 163:1584-1590
6. Warren DK, Quadir WW, Hollenbeak CS, et al: Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med 2006; 34:2084-2089
7. Dimick JB, Pelz RK, Consunji R, et al: Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001; 136:229-234
8. Higuera F, Rangel-Frausto MS, Rosenthal VD, et al: Attributable cost and length of stay for patients with central venous catheterassociated bloodstream infection in Mexico City intensive care units: A prospective, matched analysis. Infect Control Hosp Epidemiol 2007; 28:31-35
9. Laupland KB, Lee H, Gregson DB, et al: Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect 2006; 63:124-132
10. Rosenthal VD, Guzman S, Migone O, et al: The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis. Am J Infect Control 2003; 31:475-480
11. Digiovine B, Chenoweth C, Watts C, et al: The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976-981
12. Orsi GB, Di Stefano L, Noah N: Hospitalacquired, laboratory-confirmed bloodstream infection: Increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002; 23:190-197
13. Shannon RP, Patel B, Cummins D, et al: Economics of central line-associated bloodstream infections. Am J Med Qual 2006; 21: 7S-16S.
14. Eggimann P, Harbarth S, Constantin MN, et al: Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355:1864-1868
15. Coopersmith CM, Rebmann TL, Zack JE: Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002; 30:59-64
16. Données nationales: Réseau d'alerte d'investigation et de surveillance des infections nosocomiales (RAISIN). Surveillance des infections nosocomiales en réanimation adulte. France, résultats 2006. Available at: http://www.invs.sante.fr/surveillance/raisin/. Accessed September 1, 2011.
17. Zuschneid I, Schwab F, Geffers C, et al: Reducing central venous catheter-associated primary bloodstream infections in intensive care units is possible: Data from the German nosocomial infection surveillance system. Infect Control Hosp Epidemiol 2003; 24: 501-505
18. Pronovost P, Needham D, Berenholtz S, et al: An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-2732
19. Timsit JF, Schwebel C, Bouadma L, et al: Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: A randomized controlled trial. JAMA 2009; 301:1231-1241
20. Hockenhull JC, Dwan KM, Smith GW, et al: The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: A systematic review. Crit Care Med 2009; 37:702-712
21. Timsit JF: [Updating of the 12th consensus conference of the Sociétéde Réanimation de langue francaise (SRLF): Catheter related infections in the intensive care unit]. Ann Fr Anesth Reanim 2005; 24:315-322
22. Wilkinson DS, Fregert S, Magnusson B, et al: Terminology of contact dermatitis. Acta Derm Venereol 1970; 50:287-292
23. Beyersmann J, Gastmeier P, Grundmann H, et al: Use of multistate models to assess pro longation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006; 27:493-499
24. Wangler M, Beyersmann J, Schumacher M: ChangeLOS: An R-package for change in length of hospital stay based on the Aalen-Johansen estimator. The Newsletter of the R Project 2006; 6:31-35
25. Safdar N, Maki DG: The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004; 30:62-67
26. Timsit JF: Diagnosis and prevention of catheter-related infections. Curr Opin Crit Care 2007; 13:563-571
27. Ho KM, Litton E: Use of chlorhexidineimpregnated dressing to prevent vascular and epidural catheter colonization and infection: A meta-analysis. J Antimicrob Chemother 2006; 58:281-287
28. Ruschulte H, Franke M, Gastmeier P, et al: Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: A randomized controlled trial. Ann Hematol 2009; 88: 267-272
29. Blot SI, Depuydt P, Annemans L, et al: Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 2005; 41:1591-1598
30. Beyersmann J, Kneib T, Schumacher M, et al: Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol 2009; 30:273-276
31. Dasta JF, McLaughlin TP, Mody SH, et al: Daily cost of an intensive care unit day: The contribution of mechanical ventilation. Crit Care Med 2005; 33:1266-1271
32. O'Grady NP, Alexander M, Burns LA, et al: Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52:e162-e193
33. Edwards JR, Peterson KD, Mu Y, et al: National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37:783-805
34. Pronovost PJ, Goeschel CA, Colantuoni E, et al: Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: Observational study. BMJ 2010; 340:c309
35. Lucet JC, Bouadma L, Zahar JR, et al: Infectious risk associated with arterial catheters compared with central venous catheters. Crit Care Med 2010; 38:1030-1035
36. Koh DB, Gowardman JR, Rickard CM, et al: Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters. Crit Care Med 2008; 36:397-402
37. TraoréO, Liotier J, Souweine B: Prospective study of arterial and central venous catheter colonization and of arterial-and central venous catheter-related bacteremia in intensive care units. Crit Care Med 2005; 33: 1276-1280
38. Hockenhull JC, Dwan K, Boland A, et al: The clinical effectiveness and cost-effectiveness of central venous catheters treated with antiinfective agents in preventing bloodstream infections: A systematic review and economic evaluation. Health Technol Assess 2008; 12: iii-iv, xi-xii, 1-154
39. Veenstra DL, Saint S, Sullivan SD: Costeffectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282:554-560